Archive explorer

Browse & search snapshots

Important note

Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.

For background on coverage and capture methods, see Methods & coverage.

Browse archived sites

Browse all sources →

Archived 26: Summary of NACI updated guidance of December 3, 2021: Booster COVID-19 vaccine doses in Canada [2021-12-03] - Canada.ca

Health CanadaCaptures 3Latest capture Apr 18, 2025en
ViewDetailsAll snapshots

Archived 26: Summary of NACI updated guidance of December 3, 2021: Booster COVID-19 vaccine doses in Canada [2021-12-03] - Canada.ca We have archived this page and will not be updating it. You can use it for research or reference.…

Original URLwww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-booster-covid-19-vaccine-doses/summary.html

Archived 33: Summary of NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine - Canada.ca

Health CanadaCaptures 3Latest capture Apr 18, 2025en
ViewDetailsAll snapshots

Archived 33: Summary of NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine - Canada.ca We have archived this page and will not be updating it. You can use it for research or…

Original URLwww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-novavax-nuvaxovid-covid-19-vaccine/summary-february-17-2022.html

Archived 34: Summary of NACI statement of March 11, 2022: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) - Canada.ca

Health CanadaCaptures 3Latest capture Apr 18, 2025en
ViewDetailsAll snapshots

Archived 34: Summary of NACI statement of March 11, 2022: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) - Canada.ca We have archived this page and will not be updating it. You can use it for research or…

Original URLwww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-medicago-covid-19-vaccine/summary-march-11-2022.html

Archived 31: Summary of the NACI rapid response of January 28, 2022: Guidance on the use of booster COVID-19 vaccine doses in adolescents 12 to 17 years of age - Canada.ca

Health CanadaCaptures 3Latest capture Apr 18, 2025en
ViewDetailsAll snapshots

Archived 31: Summary of the NACI rapid response of January 28, 2022: Guidance on the use of booster COVID-19 vaccine doses in adolescents 12 to 17 years of age - Canada.ca We have archived this page and will not be updating it. You…

Original URLwww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-guidance-use-booster-covid-19-vaccine-doses-adolescents-12-17-years-age/summary.html

Archived 33: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine [2022-02-17] - Canada.ca

Health CanadaCaptures 3Latest capture Apr 18, 2025en
ViewDetailsAll snapshots

Archived 33: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine [2022-02-17] - Canada.ca We have archived this page and will not be updating it. You can use it for research or reference. Français fr…

Original URLwww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-novavax-nuvaxovid-covid-19-vaccine.html

Archived 31: NACI rapid response: Guidance on the use of booster COVID-19 vaccine doses in adolescents 12 to 17 years of age [2022-01-28] - Canada.ca

Health CanadaCaptures 3Latest capture Apr 18, 2025en
ViewDetailsAll snapshots

Archived 31: NACI rapid response: Guidance on the use of booster COVID-19 vaccine doses in adolescents 12 to 17 years of age [2022-01-28] - Canada.ca We have archived this page and will not be updating it. You can use it for…

Original URLwww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-guidance-use-booster-covid-19-vaccine-doses-adolescents-12-17-years-age.html

Archived 32: NACI rapid response: Updated guidance on COVID-19 vaccination timing for individuals previously infected with SARS-CoV-2 [2022-02-04] - Canada.ca

Health CanadaCaptures 3Latest capture Apr 18, 2025en
ViewDetailsAll snapshots

Archived 32: NACI rapid response: Updated guidance on COVID-19 vaccination timing for individuals previously infected with SARS-CoV-2 [2022-02-04] - Canada.ca We have archived this page and will not be updating it. You can use it…

Original URLwww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-guidance-covid-19-vaccination-timing-individuals-previously-infected-sars-cov-2.html

Archived 32: Summary of NACI rapid response of February 4, 2022: Updated guidance on COVID-19 vaccination timing for individuals previously infected with SARS-CoV-2 - Canada.ca

Health CanadaCaptures 3Latest capture Apr 18, 2025en
ViewDetailsAll snapshots

Archived 32: Summary of NACI rapid response of February 4, 2022: Updated guidance on COVID-19 vaccination timing for individuals previously infected with SARS-CoV-2 - Canada.ca We have archived this page and will not be updating it.…

Original URLwww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-guidance-covid-19-vaccination-timing-individuals-previously-infected-sars-cov-2/summary.html

Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age [2022-03-17] - Canada.ca

Health CanadaCaptures 3Latest capture Apr 18, 2025en
ViewDetailsAll snapshots

Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age [2022-03-17] - Canada.ca We have archived this page and will not be updating it. You can use it for…

Original URLwww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-11-years-age.html

Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age - Canada.ca

Health CanadaCaptures 3Latest capture Apr 18, 2025en
ViewDetailsAll snapshots

Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age - Canada.ca We have archived this page and will not be updating it. You can…

Original URLwww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-11-years-age/summary-march-17-2022.html
Page 3918 of 3977Showing 39171-39180 of 39762
« First← PrevNext →Last »

Early release: coverage and features are still expanding.